Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery

Obes Surg. 2018 Feb;28(2):378-388. doi: 10.1007/s11695-017-2851-y.

Abstract

Background: This study aims to compare the post-prandial curves of glucose, insulin, GLP-1, and GLP-2 among individuals with Crohn's disease (CD), obese individuals before and after bariatric surgery, and healthy controls.

Methods: This an exploratory cross-sectional study that involved five groups of patients (two groups of individuals with CD-active and inactive), bariatric patients (pre- and post-surgery, who were their own controls), and a distinct separated control group of healthy volunteers. C-reactive protein (CRP) levels and the post-prandial curves of glucose, insulin, GLP-1, and GLP-2 curves were assessed and compared.

Results: The pre-RYGB group presented significantly higher levels of CRP than the post-RYGB (p = 0.001) and the control group (p = 0.001). The inactive CD group presented a higher post-prandial GLP-1 area under the curve (AUC) than the pre-RYGB group (p = 0.009). The post-RYGB group presented significantly higher AUCs of GLP-2 than the pre-RYGB group (p < 0.0001), both inactive and active CD groups (p < 0.0001 in both situations), and the control group (p = 0.002). The pre-RYGB group presented a significantly higher AUC of glucose than the post-RYGB (p = 0.02) and both active and inactive CD groups (p = 0.019 and p = 0.046, respectively). The pre-RYGB group presented a significantly higher AUC of insulin than the control (p = 0.005) and both CD groups (p < 0.0001).

Conclusions: Obesity is associated with an inflammatory state comparable to the one observed in CD; inflammation may also be enrolled in the blockade of GLP-2. CD individuals present a more incretin-driven pattern of glucose metabolism, as a way to prevent hypoglycemia and compensate the carbohydrate malabsorption and GLP-2 blockade.

Keywords: Bariatric surgery; Crohn’s disease; Glucagon-like peptide 1; Glucagon-like peptide 2; Obesity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bariatric Surgery*
  • Blood Glucose / metabolism*
  • Case-Control Studies
  • Crohn Disease / blood
  • Crohn Disease / metabolism*
  • Cross-Sectional Studies
  • Female
  • Glucagon-Like Peptide 1 / metabolism*
  • Glucagon-Like Peptide 2 / metabolism*
  • Glucose Tolerance Test
  • Humans
  • Insulin / metabolism
  • Male
  • Middle Aged
  • Obesity, Morbid / blood
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / surgery*
  • Postoperative Period
  • Postprandial Period / physiology
  • Preoperative Period
  • Young Adult

Substances

  • Blood Glucose
  • Glucagon-Like Peptide 2
  • Insulin
  • Glucagon-Like Peptide 1